Profile
International Journal of Clinical Research & Trials Volume 4 (2019), Article ID 4:IJCRT-140, 5 pages
https://doi.org/10.15344/2456-8007/2019/140
Research Article
Outcomes of a Transitional Care Clinic to Reduce Heart Failure Readmissions at an Urban Academic Medical Center

Justin Lee, Felix Reyes, Minhazul Islam, Mafuzur Rahman, Miguel Ramirez, Jonathan Francois and Samy I. McFarlane*

Department of Medicine, SUNY Downstate Health Science University, Brooklyn, NY 11203, USA
Prof. Samy I. McFarlane, Division of Endocrinology, Department of Internal Medicine, State University of New York, Downstate Medical Center, Brooklyn, New York,11203, USA, Tel: 718-270-6707, Fax: 718- 270-4488; E-mail: smcfarlane@downstate.edu
01 December 2019; 28 December 2019; 30 December 2019
Lee J, Reyes F, Islam M, Rahman M, Ramirez M, et al. (2019) Outcomes of a Transitional Care Clinic to Reduce Heart Failure Readmissions at an Urban Academic Medical Center. Int J Clin Res Trials 4: 140. doi: https://doi.org/10.15344/2456-8007/2019/140
This work is supported, in part, by the efforts of Dr. Moro O. Salifu M.D., M.P.H., M.B.A., M.A.C.P., Professor and Chairman of Medicine through NIH Grant number S21MD012474.

Abstract

Heart Failure (HF) is one of the leading hospital readmission diagnoses in the United States. It is a major challenge in today’s healthcare environment to reduce hospital readmissions for HF and much of the expenditure on HF is on in-hospital treatment. In the USA, risk factors for readmission with HF include being African American, low-socioeconomic status, Medicare, Medicaid, self-pay/no insurance and drug abuse. The Transitional Care Clinic (TCC) model established at our institution integrated multiple facets of chronic HF management, including early post-discharge follow-up, phone call reminders as well as clinical pharmacists and nurse practitioner’s integration into the treatment team.

Of 488 HF admissions to our institution from March 2015 until May 2017, mean age = 65 years (SD 13.03), 262 patients were males (53.6%) and 463 patients (94%) were Blacks. There was a total of 121 readmissions within 30 days after discharge (24.8%) and 43 readmissions 7 days after discharge (8.81%) during our study period. 159 patients (32.58%) followed up in our TCC, while 329 patients (67.41%) did not at TCC. Within 7 days post discharge, there was 3 (1.9%) Vs 40 (12.2%) readmissions for TCC and non-TCC groups respectively, P<0.01. There was 18 (11.32%) Vs 103(31.31%) readmissions within 30 days post discharge for TCC and non-TCC groups respectively P<0.01.

Among high readmission risk and predominantly black population with HF, TCC resulted in significantly lower hospital readmission rate within 7 days and within 30 days of initial discharge. These data help inform policy makers regarding the effectiveness of TCC model for resource allocation and broader implementation, particularly among high risk population with the potential of cost saving and better patient outcomes.